Vir Biotechnology Inc at Needham Healthcare Conference (Virtual) Transcript
Good morning, everyone. Thank you for joining the 21st Annual Needham Healthcare Conference. My name is Joey Stringer; I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, Vir Biotechnology. And joining us today from Vir is CMO, Phil Pang. (Conference Instructions)
And with that, we'll get started. I'll turn it over to Phil for some brief opening remarks, and then we'll go ahead and get started with the chat.
Joey, thank you so much. And as always, I want to begin by a disclaimer that I will be making some forward-looking statements and that for additional details, you should see our SEC filings.
So, Joey, just to begin, this is really an extraordinary and pivotal time for Vir, and I really want to emphasize that. In just five years since we were founded, we've brought a transformative life-saving medication to patients called sotrovimab, which is our COVID
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |